Correlation Between Ayala Pharmaceuticals and CEL SCI

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Ayala Pharmaceuticals and CEL SCI at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Ayala Pharmaceuticals and CEL SCI into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Ayala Pharmaceuticals and CEL SCI Corp, you can compare the effects of market volatilities on Ayala Pharmaceuticals and CEL SCI and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Ayala Pharmaceuticals with a short position of CEL SCI. Check out your portfolio center. Please also check ongoing floating volatility patterns of Ayala Pharmaceuticals and CEL SCI.

Diversification Opportunities for Ayala Pharmaceuticals and CEL SCI

0.19
  Correlation Coefficient

Average diversification

The 3 months correlation between Ayala and CEL is 0.19. Overlapping area represents the amount of risk that can be diversified away by holding Ayala Pharmaceuticals and CEL SCI Corp in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on CEL SCI Corp and Ayala Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Ayala Pharmaceuticals are associated (or correlated) with CEL SCI. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of CEL SCI Corp has no effect on the direction of Ayala Pharmaceuticals i.e., Ayala Pharmaceuticals and CEL SCI go up and down completely randomly.

Pair Corralation between Ayala Pharmaceuticals and CEL SCI

If you would invest  138.00  in Ayala Pharmaceuticals on August 28, 2024 and sell it today you would earn a total of  0.00  from holding Ayala Pharmaceuticals or generate 0.0% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthInsignificant
Accuracy1.56%
ValuesDaily Returns

Ayala Pharmaceuticals  vs.  CEL SCI Corp

 Performance 
       Timeline  
Ayala Pharmaceuticals 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Ayala Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of comparatively stable basic indicators, Ayala Pharmaceuticals is not utilizing all of its potentials. The current stock price uproar, may contribute to short-horizon losses for the private investors.
CEL SCI Corp 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days CEL SCI Corp has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unfluctuating performance in the last few months, the Stock's basic indicators remain very healthy which may send shares a bit higher in December 2024. The recent disarray may also be a sign of long period up-swing for the firm investors.

Ayala Pharmaceuticals and CEL SCI Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Ayala Pharmaceuticals and CEL SCI

The main advantage of trading using opposite Ayala Pharmaceuticals and CEL SCI positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Ayala Pharmaceuticals position performs unexpectedly, CEL SCI can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in CEL SCI will offset losses from the drop in CEL SCI's long position.
The idea behind Ayala Pharmaceuticals and CEL SCI Corp pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Price Exposure Probability module to analyze equity upside and downside potential for a given time horizon across multiple markets.

Other Complementary Tools

Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume